Home » Topics » BioWorld Science

BioWorld Science
RSS

DalCor initiates phase II study of dalcetrapib in patients with COVID-19

Jan. 12, 2021

Hawaii Biotech identified new botulinum neurotoxin inhibitors

Jan. 12, 2021

Shanghai Institute of Materia Medica discloses PRDX1 inhibitors

Jan. 12, 2021

Nanjing Greepharma patents new ARG1 inhibitors

Jan. 12, 2021

Chinese investigators divulge EGFR inhibitors

Jan. 12, 2021

Dyne reports preclinical data from DM1 program

Jan. 12, 2021

Viralym-M enters phase III for virus-associated hemorrhagic cystitis

Jan. 12, 2021

Forma begins phase II/III study of FT-4202 in sickle cell disease

Jan. 12, 2021

rVSV-deltaG-spike vaccine protects hamsters against SARS-CoV-2 challenge

Jan. 12, 2021

Cara opens phase II trial of oral difelikefalin for notalgia paresthetica pruritus

Jan. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...